PL1861080T3 - Idebenon do leczenia dystrofii mięśniowych - Google Patents
Idebenon do leczenia dystrofii mięśniowychInfo
- Publication number
- PL1861080T3 PL1861080T3 PL06723554T PL06723554T PL1861080T3 PL 1861080 T3 PL1861080 T3 PL 1861080T3 PL 06723554 T PL06723554 T PL 06723554T PL 06723554 T PL06723554 T PL 06723554T PL 1861080 T3 PL1861080 T3 PL 1861080T3
- Authority
- PL
- Poland
- Prior art keywords
- idebenone
- treatment
- muscular dystrophies
- treating
- muscular dystrophy
- Prior art date
Links
- 201000006938 muscular dystrophy Diseases 0.000 title abstract 3
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004135 idebenone Drugs 0.000 title abstract 2
- 208000031229 Cardiomyopathies Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05006137 | 2005-03-21 | ||
| PCT/EP2006/002536 WO2006100017A1 (en) | 2005-03-21 | 2006-03-20 | Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies |
| EP06723554A EP1861080B1 (en) | 2005-03-21 | 2006-03-20 | Idebenone for the treatment of muscular dystrophies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1861080T3 true PL1861080T3 (pl) | 2010-10-29 |
Family
ID=36572153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06723554T PL1861080T3 (pl) | 2005-03-21 | 2006-03-20 | Idebenon do leczenia dystrofii mięśniowych |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7977388B2 (https=) |
| EP (1) | EP1861080B1 (https=) |
| JP (1) | JP4896123B2 (https=) |
| AT (1) | ATE468849T1 (https=) |
| AU (1) | AU2006226623B2 (https=) |
| CA (1) | CA2602290C (https=) |
| CY (1) | CY1110182T1 (https=) |
| DE (1) | DE602006014514D1 (https=) |
| DK (1) | DK1861080T3 (https=) |
| ES (1) | ES2345353T3 (https=) |
| MX (1) | MX2007011571A (https=) |
| NZ (1) | NZ561235A (https=) |
| PL (1) | PL1861080T3 (https=) |
| PT (1) | PT1861080E (https=) |
| SI (1) | SI1861080T1 (https=) |
| WO (1) | WO2006100017A1 (https=) |
| ZA (1) | ZA200707833B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103271935A (zh) | 2006-08-01 | 2013-09-04 | 普里克萨斯医药股份有限公司 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| EP1891946A1 (en) * | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| WO2009079562A2 (en) | 2007-12-17 | 2009-06-25 | The Regents Of The University Of Michigan | Compositions and methods for treating and preventing skeletal muscle deficiencies |
| SI2108366T1 (sl) * | 2008-04-09 | 2012-01-31 | Santhera Pharmaceuticals Ch | Idebenon za zdravljenje respiratorne bolezni pri miĺ iäśni distrofiji |
| EP2246048A1 (en) | 2009-04-30 | 2010-11-03 | Santhera Pharmaceuticals (Schweiz) AG | Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis |
| DK2605769T3 (en) | 2010-08-16 | 2016-10-24 | Santhera Pharmaceuticals (Schweiz) Ag | Benzoquinonderivater for the treatment of mitochondrial diseases of the eye |
| CN103086861B (zh) * | 2012-11-12 | 2015-09-16 | 刘炜 | 羟癸基苯醌衍生物及其用途 |
| US20230047313A1 (en) * | 2019-12-16 | 2023-02-16 | Children`S Medical Center Corporation | Treating heart disease in muscular dystrophy patients |
| EP4351545A1 (en) | 2021-06-07 | 2024-04-17 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
| CN113827585B (zh) * | 2021-10-27 | 2023-04-11 | 山东大学齐鲁医院 | 艾地苯在治疗肢带型肌营养不良2g型中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8562998A (en) | 1997-08-12 | 1999-03-01 | Takeda Chemical Industries Ltd. | Idebenone-containing preparation for percutaneous administration |
| JPH11116470A (ja) | 1997-08-12 | 1999-04-27 | Takeda Chem Ind Ltd | イデベノン含有経皮投与製剤 |
| US20030013772A1 (en) * | 2000-02-23 | 2003-01-16 | Murphy Michael A. | Composition, synthesis and therapeutic applications of polyamines |
| CA2272971C (en) | 1998-10-29 | 2008-01-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Quinone derivatives for treating or preventing diseases associated with iron overload |
| US20040081961A1 (en) * | 2001-05-04 | 2004-04-29 | Delegeane Angelo M | Proteases |
| EP1618881A1 (en) | 2004-07-20 | 2006-01-25 | Santhera Pharmaceuticals (Schweiz) GmbH | Use of non-glucocorticoid steroids for the treatment of muscular dystrophy |
-
2006
- 2006-03-20 SI SI200630706T patent/SI1861080T1/sl unknown
- 2006-03-20 MX MX2007011571A patent/MX2007011571A/es active IP Right Grant
- 2006-03-20 JP JP2008502302A patent/JP4896123B2/ja not_active Expired - Fee Related
- 2006-03-20 PT PT06723554T patent/PT1861080E/pt unknown
- 2006-03-20 WO PCT/EP2006/002536 patent/WO2006100017A1/en not_active Ceased
- 2006-03-20 US US11/886,388 patent/US7977388B2/en not_active Expired - Fee Related
- 2006-03-20 ES ES06723554T patent/ES2345353T3/es not_active Expired - Lifetime
- 2006-03-20 CA CA2602290A patent/CA2602290C/en not_active Expired - Fee Related
- 2006-03-20 DK DK06723554.9T patent/DK1861080T3/da active
- 2006-03-20 NZ NZ561235A patent/NZ561235A/en not_active IP Right Cessation
- 2006-03-20 AT AT06723554T patent/ATE468849T1/de active
- 2006-03-20 EP EP06723554A patent/EP1861080B1/en not_active Expired - Lifetime
- 2006-03-20 PL PL06723554T patent/PL1861080T3/pl unknown
- 2006-03-20 AU AU2006226623A patent/AU2006226623B2/en not_active Ceased
- 2006-03-20 DE DE602006014514T patent/DE602006014514D1/de not_active Expired - Lifetime
-
2007
- 2007-09-13 ZA ZA200707833A patent/ZA200707833B/xx unknown
-
2010
- 2010-07-06 CY CY20101100628T patent/CY1110182T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006014514D1 (https=) | 2010-07-08 |
| AU2006226623B2 (en) | 2010-04-22 |
| WO2006100017A1 (en) | 2006-09-28 |
| ATE468849T1 (de) | 2010-06-15 |
| PT1861080E (pt) | 2010-06-17 |
| SI1861080T1 (sl) | 2010-08-31 |
| MX2007011571A (es) | 2007-12-06 |
| JP2008533182A (ja) | 2008-08-21 |
| CY1110182T1 (el) | 2015-01-14 |
| US20090012050A1 (en) | 2009-01-08 |
| EP1861080B1 (en) | 2010-05-26 |
| US7977388B2 (en) | 2011-07-12 |
| NZ561235A (en) | 2010-12-24 |
| EP1861080A1 (en) | 2007-12-05 |
| CA2602290A1 (en) | 2006-09-28 |
| DK1861080T3 (da) | 2010-09-06 |
| ES2345353T3 (es) | 2010-09-21 |
| JP4896123B2 (ja) | 2012-03-14 |
| AU2006226623A1 (en) | 2006-09-28 |
| CA2602290C (en) | 2012-01-17 |
| ZA200707833B (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110182T1 (el) | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων | |
| SI1978947T1 (sl) | Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij | |
| PL2436338T3 (pl) | Urządzenie do leczenia zwieraczy tkanki ciała i tym podobnych | |
| WO2004103301A3 (en) | Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents | |
| EP1991218A4 (en) | USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES | |
| ZA200807936B (en) | Compounds for the treatment of spinal muscular atrophy and other uses | |
| WO2007146426A3 (en) | Nanoshells for drug delivery | |
| EP1731113A4 (en) | MEDICAL TREATMENT KIT | |
| IL181234A0 (en) | Mixture of phytosterol ester(s) and 1,3-diglycerides(s) for use in the treatment of medical conditions | |
| IL204990A0 (en) | Use of 3,11 b-cis - dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis | |
| IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
| MX2009008873A (es) | Composicion util para el tratamiento de diabetes tipo 2. | |
| GB0300428D0 (en) | Medical treatment | |
| GB0310147D0 (en) | A composition for use in the treatment of a skin condition in a subject | |
| SI1937245T1 (sl) | Spojina uporabna za preprečevanje in zdravljenjeleve ventrikularne hipertofije pri dializiranih pacientih | |
| HK1153406A (en) | Piperlongumine and piperlongumine analogs for use in the treatment of cancer | |
| AU2005901429A0 (en) | Medical Apparatus and the Treatment of Lymphoedema | |
| GB0419703D0 (en) | Medical treatment | |
| GB0415318D0 (en) | Medical treatment | |
| HK1126656A (en) | Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain | |
| AU2004903432A0 (en) | Medical treatment | |
| AU2004903526A0 (en) | Medical treatment | |
| HK1104480A (en) | Method for a treatment with a medicament combination and medicament combinations suitable for the same | |
| GB0301521D0 (en) | Medical treatment | |
| GB0301519D0 (en) | Medical treatment |